Postterm closure of the cavum septi pellucidi and developmental outcome in premature infants

Howard Needelman1, Bruce Schroeder, Matthew Sweeney

  • 1Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68198-5440, USA. hneedelm@unmc.edu

Insights

The cavum septum pellucidum (CSP) in premature infants often closes by term. Persistence of CSP in these infants does not impact developmental outcomes, suggesting it

Area of Science:

  • Neonatal neurology
  • Developmental pediatrics
  • Neuroimaging in infants

Background:

  • The cavum septum pellucidum (CSP) is a midline brain structure.
  • Premature infants born at 26-27 weeks gestation may exhibit delayed CSP closure.
  • Understanding CSP natural history is crucial for assessing neurodevelopmental risks.

Purpose of the Study:

  • To investigate the natural history of cavum septum pellucidum (CSP) closure in extremely premature infants.
  • To compare developmental outcomes between infants with and without persistent CSP at term-equivalent age.
  • To determine if persistent CSP is an independent risk factor for developmental delay.

Main Methods:

  • Longitudinal ultrasound follow-up of 72 premature infants (26-27 weeks gestation).
  • Assessment of CSP status at approximately term-equivalent age (35-42 weeks postconception).
  • Comparison of neurodevelopmental outcomes between infants with and without persistent CSP.

Main Results:

  • 35 out of 72 infants had persistent CSP visualized on ultrasound at term-equivalent age.
  • No significant difference in developmental outcomes was observed between infants with and without persistent CSP.
  • Early closure of CSP did not correlate with improved developmental outcomes compared to persistent CSP.

Conclusions:

  • Persistence of the cavum septum pellucidum (CSP) through term-equivalent age is common in extremely premature infants.
  • Persistent CSP is not an independent risk factor for developmental delay in this cohort.
  • Current findings suggest a need to re-evaluate the clinical significance of persistent CSP in neonatal neurodevelopmental assessments.